Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Reata Pharmaceuticals Inc (RETA)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Prosight Capital

Lawrence Hawkins

80,155 $6,553 -4% 3.65%
2. 660,000 $53,962 +47% 3.5%
3. 23,900 $1,954 -41% 2.07%
4.
Deerfield Management

James E. Flynn

294,000 $24,037 -52% 0.86%
5.
Driehaus Capital

Richard Driehaus

186,827 $15,275 0.47%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$59.90 1,418 3,023,349 2018-12-12 Filing
$60.07 52,809 3,021,931 2018-12-11 Filing
$59.53 29,347 2,969,122 2018-12-10 Filing
$58.62 1,078 2,939,775 2018-12-10 Filing
$57.93 26,174 2,938,697 2018-12-10 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$68.13 1,053 Officer 0 2018-11-07 Filing
$66.64 3,697 Officer 1,053 2018-11-07 Filing
$59.48 4,750 Officer 0 2018-11-01 Filing
$57.08 14,250 Officer 0 2018-10-23 Filing
$51.48 140 Officer 0 2018-07-23 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 240,000 $19,622 22.37%
2. 2,912,523 $238,128 16.57%
3. 60,775 $4,969 3.8%
4. 400,000 $32,704 3.62%
5. 32,000 $2,616 1.71%